Overview
Senomyx nose a good thing when it smells it. The company has identified human receptor genes related to the detection of smells and tastes, and, using this genetic research, the company is developing sweet, salty, and savory flavor enhancers and bitter taste modulators. Potential products include agents that can block bitter tastes in coffee and make low-sodium snacks taste salty. Senomyx collaborates with the likes of PepsiCo, Nestlé, and
...
Read More Firmenich. The company also works with Japan's largest flavors company, Ajinomoto, which has opened up the Asian market for Senomyx. In October 2018, Senomyx was acquired by Switzerland's Firmenich.
Read Less
Read More Firmenich. The company also works with Japan's largest flavors company, Ajinomoto, which has opened up the Asian market for Senomyx. In October 2018, Senomyx was acquired by Switzerland's Firmenich.
Read Less
Scientific Research and Development Services
,
Lessors of Nonfinancial Intangible Assets (except Copyrighted Works)
,
Professional, Scientific, and Technical Services
,
Food research
,
Franchises, selling or licensing
Accounting, Tax Preparation, Bookkeeping, and Payroll Services
,
Advertising, Public Relations, and Related Services
,
Architectural, Engineering, and Related Services
,
Computer Systems Design and Related Services
,
Legal Services
,
Management, Scientific, and Technical Consulting Services
,
Other Professional, Scientific, and Technical Services
,
Specialized Design Services
?
?
?
Actual
?
Actual
#
Actual
?
?
?
Contacts
Get in Touch with 4 Principals* and 17 Contacts
-
John PoyhonenPresident and Chief Executive Officer
-
Contact 2?
-
Contact 3?
-
Contact 4?
Dynamic search and list-building capabilities
Real-time trigger alerts
Comprehensive company profiles
Valuable research and technology reports
Financial Data
Dun & Bradstreet collects private company financials for more than 23 million companies worldwide. Find out more.
Financial data as of ? (12 month period) in USD
Annual Revenue
?
USD
Modelled
All financial statement data is in millions except per share data | Source: Morningstar
| Cash Flow (mil) | 2017 | 2016 | 2015 |
|---|---|---|---|
| Net Operating Cash | $2 | -$12 | -$8 |
| Net Investing Cash | -$1 | $9 | $6 |
| Net Financing Cash | $2 | $1 | $3 |
| Net Change in Cash | $3 | -$1 | $1 |
| Cash at Beginning of Period | $4 | $5 | $4 |
| Cash at End of Period | $6 | $4 | $5 |
| Capital Expenditure | -$1 | -$0 | -$1 |
| Assets (mil) | 2017 | 2016 | 2015 |
|---|---|---|---|
| Current Assets | |||
| Cash and Cash Equivalents | $6 | $4 | $5 |
| Accounts Receivable | $7 | $5 | $3 |
| Inventories | $2 | $2 | $2 |
| Other Current Assets | $10 | $10 | $19 |
| Asset Summary | |||
| Total Current Assets | $25 | $21 | $29 |
| Tangible Fixed Assets | $3 | $3 | $3 |
| Intangible Assets | $ | $ | $ |
| Total Assets | $28 | $24 | $33 |
| Liabilities (mil) | 2017 | 2016 | 2015 |
|---|---|---|---|
| Current Liabilities | |||
| Accounts Payable | $1 | $1 | $0 |
| Short-Term Debt | $ | $ | $ |
| Other Current Liabilities | $5 | $5 | $9 |
| Liability Summary | |||
| Total Current Liabilities | $5 | $6 | $10 |
| Long-Term Debt | $ | $ | $ |
| Other Long-Term Liabilities | $1 | $1 | $2 |
| Total Liabilities | $9 | $9 | $13 |
| Stakeholder's Equity (mil) | 2017 | 2016 | 2015 |
|---|---|---|---|
| Equity | |||
| Common Stock | $0 | $0 | $0 |
| Retained Earnings | -$280 | -$278 | -$267 |
| Equity Summary | |||
| Total Equity | $19 | $15 | $20 |
| Shares Outstanding | 47,786,793 | 45,298,403 | 44,503,820 |